317319-15-6

Basic information

• Product Name: 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE
• Synonyms: 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE;3,5-Bis(trifluoromethyl)thiobenzamide, 97%;3,5-bis(trifluoroMethyl)benzothioaMide;Benzenecarbothioamide, 3,5-bis(trifluoromethyl)-;3,5-Bis(trifluoromethyl)benzenecarbothioamide
• CAS NO: 317319-15-6
• Molecular Formula: C₉H₅F₆NS
• Molecular Weight: 273.2
• Mol File: 317319-15-6.mol
• Article Data: 7

Chemical Properties

• Melting Point: 113-115°C
• Boiling Point: 241.2°Cat760mmHg
• Flash Point: 99.7°C
• Appearance: /
• Density: 1.492g/cm³
• Vapor Pressure: 0.0363mmHg at 25°C
• Refractive Index: 1.484
• PKA: 11.95±0.29(Predicted)
• CAS DataBase Reference: 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE(317319-15-6)
• EPA Substance Registry System: 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE(317319-15-6)

Safety Data

• Hazardous Substances Data: 317319-15-6(Hazardous Substances Data)

Usage

General Description

3,5-Di(trifluoromethyl)benzene-1-carbothioamide is a chemical compound with the molecular formula C9H7F6NS. It is a thioamide derivative of benzene, with two trifluoromethyl groups attached to the 3 and 5 positions of the benzene ring. 3,5-DI(TRIFLUOROMETHYL)BENZENE-1-CARBOTHIOAMIDE is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. It has potential applications in medicinal chemistry, particularly as a potential drug candidate for the treatment of various diseases. Additionally, its unique chemical structure and properties make it a valuable tool for research and development in the field of organic chemistry.

InChI:InChI=1/C9H5F6NS/c10-8(11,12)5-1-4(7(16)17)2-6(3-5)9(13,14)15/h1-3H,(H2,16,17)

Upstream product

• 27126-93-8 3,5-bis(trifluoromethyl)benzonitrile 

Downstream Products

• 1251939-59-9 methyl 2-(2-(3,5-bis(trifluoromethyl)phenyl)thiazol-4-yl)acetate 
• 1333154-10-1 3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole 
• 1333152-22-9 (Z)-isopropyl 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate 
• 1421919-75-6 (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-difluoroazetidin-1-yl)prop-2-en-1-one 
• 1388842-44-1 (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid 
• 1393477-72-9 3-[3-[3,5-bis(trifloromoethyl)phenyl]-1H-1,2,4-triazol-1-yl]-N’-(pyrazin-2-yl)acrylohydrazide 
• 1392136-43-4 (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyridin-2-ylprop-2-enehydrazide 
• 1421920-37-7 C₁₈H₁₆F₆N₄O₂ 
• 1421923-74-1 C₁₇H₁₅F₆N₅O 
• 1421923-75-2 C₁₉H₁₄F₆N₆O 
• 1421923-76-3 C₁₈H₁₃F₆N₇O 
• 1421923-79-6 C₁₉H₁₄F₆N₆O 
• 1421923-80-9 C₁₇H₁₀ClF₆N₇O 
• 1421923-81-0 C₁₈H₁₂F₆N₆O 

Relevant articles and documents

Acryloyl group-containing nuclear transport modulator and uses thereof

The invention relates to a novel acryloyl-containing compound as well as a preparation method and application thereof. Specifically, the invention relates to an acryloyl-containing compound as shown in a formula (1) and a preparation method thereof, and a

Selinexor

Advances in the understanding of the pathophysiology, molecular biology and genetics of solid tumors and hematological malignancies have culminated in the development of novel targeted therapeutic agents leading to improved prognosis and quality of life for cancer patients. Despite these advances, prognosis remains poor for many cancer patients, and there is an unmet need for new therapeutic options. Exportin-1 (XPO1) is a nuclear export receptor that is responsible for exporting proteins, including tumor suppressor proteins, out of the nucleus. Nuclear export of tumor suppressor proteins is an important mechanism by which cancer cells avoid apoptosis and cell death. Overexpression of XPO1 imparts poor prognosis, indicating that XPO1 inhibition can be a potential therapeutic target. Recently, selective inhibitors of nuclear export (SINE) drugs have been developed. Selinexor (KPT-330) is an oral SINE with a favorable toxicity profile and demonstrated to have preclinical and clinical activity against a broad range of solid tumors and hematological malignancies.

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.